Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Anti-CD20 B cell depletion is associated with elevated mucosal-originating circulating regulatory IgA B cells in multiple sclerosis.
Cortical gray matter myelin cuts energy cost of spike propagation without increasing conduction velocity.
Glucocorticoid exposure and social support deficits as longitudinal predictors of long-term neuropsychiatric damage in SLE: insights from the LUMINA cohort (LXXXIII).
Comprehensive Analysis of Ozanimod-Related Adverse Events Based on the FAERS Database.
A Delicate Balance: Immunotherapy for Endometrial Cancer in a Patient With Multiple Sclerosis.
All anti-CD20 therapies are equivalent in treating MS-YES.
"All anti-CD20 therapies are equivalent in treating MS": Commentary.
All anti-CD20 therapies are equivalent in treating MS: No.
Network dynamics under neuronal degradation: A comparison between modular and small-world topologies.
Disease-modifying effects on chronic axon damage and white matter degeneration with 4-aminopyridine after acute traumatic brain injury.
Effectiveness and Safety of Plasmapheresis in MOGAD Attacks: A Systematic Review and Meta-Analysis.
Nucleus-specific thalamic volumes and retinal thickness in pediatric-onset multiple sclerosis: a cross-sectional study.
Tumefactive demyelinating disorders as neoplasm mimics: description of a typical case and literature review.
Reply to "Trigeminal root dislocation subtends focal demyelination of primary trigeminal afferents in patients with trigeminal neuralgia".
Ocrelizumab-induced colitis acutely managed with ciclosporin.
Potential benefits of music-based therapies on rehabilitation outcomes in people with multiple sclerosis: a systematic review.
Spatial Transcriptomic Decoupling and Magnetic Resonance Imaging Identify the Genetic and Cytoarchitectonic Correlates of Regional Vulnerability in Alzheimer's Disease.
Modulation of TH17 cell activity by REV-ERB agonists: path toward novel treatments for canine meningoencephalitis of unknown origin.
The emerging role of B cells in immune-mediated demyelinating diseases: mechanisms and therapeutic implications.
CGRP: the immune system's double agent - context-dependent roles in inflammation, resolution and cancer.
Establishing demographic-based normative values for neurofilament light chain and glial fibrillary acidic protein in serum and plasma samples.
When the Disc Strikes: Rethinking Fibrocartilaginous Embolism.
Targeting cannabinoid receptor 1 for multiple sclerosis: molecular docking and dynamic insights of berberine and curcumin as potential therapeutic agents.
Comparative Analysis of Choroid Plexus Volume Between MOG Antibody Associated Disease and Multiple Sclerosis.
B-cell repopulation and postpartum MS disease activity following ofatumumab cessation for pregnancy in women with multiple sclerosis.

Pages